Table 3.
Antineoplastic drugs | Antibiotics and Antiviral drugs | Drugs for epileptic, Parkinson, and cognition | Traditional Chinese medicine | Other drugs |
---|---|---|---|---|
Cisplatin | Gentamicin | Carbamazepine | Ligustrazine | 131I-MnTBAP |
Dong et al., 2002 | Liu et al., 1994 | Zhou et al., 2005 | Wang et al., 2006 | Diao et al., 2013 |
Jia et al., 2004 | Sulfanilamide | Zhou et al., 2008 | Li et al., 2008 | Nerve growth factor |
Yin 2017 | Xu & Wang 1995 | Zhang et al., 2011 (2) | Xiao & Ping 2009 | Zhao et al., 2015 |
Nimustine | Rifampicin | Sodium Valproate | Liu 2015 | Fentanyl |
Shi & Zhao 2008 | Wu et al., 2004 | Chen et al., 2007 | Salvia miltiorrhiza | Wang 2006 |
Methotrexate | Clindamycin | Zhang et al., 2007 | Zhang et al., 2007 | As2O3 |
Gao 2009 | Wang 2006 | Liu & Gao 2007 | Liu et al., 2008 | Xiao et al., 2007 |
Guo et al., 2015 | Cefatriaxone | Phenytoin sodium | Ginsenoside | Neurotoxin nanoparticle |
Vincristine | Wei et al., 2010 | Ren 2016 | Wang et al., 2009 | Chai et al., 2009 |
Zhu 2009 | Meropenem | Amantadine Hydrochloride | Ferulic acid | |
Irinotecan | Xin et al., 2014 | Wang 2006 | Lin et al., 2008 | |
Cao 2013 | Azidothymidine | Huperzine | Puerarin | |
Erlotinib | Wu et al., 2009 | Zhang et al., 2011 (1) | Tang et al., 2016 | |
Wei 2016 | Asiaticoside | |||
Adriamycin | Hou et al., 2016 | |||
Wu 2016 | HSYA | |||
Quercetin | Wu et al., 2011 | |||
Wang et al., 2012 | Jujuboside | |||
Kaempferol | Wang et al., 2011 | |||
Zhang 2014 | Geniposide | |||
Zhang et al., 2015 | Dong et al., 2012 | |||
Yu et al., 2012 | ||||
Paeonol | ||||
Chen 2005 |
HSYA: hydroxysafflor yellow A; 131I-MnTBAP: manganese porphyrin labeled by 131I.